Lantern Pharma (LTRN) - Cekelan dhuwit saben saham

Simbol lan logo merek Lantern Pharma Inc (LTRN)

Lantern Pharma Inc. (LTRN) is optimizing supply chains via AI to minimize the risk of laboratory downtime. Cash per share distribution shows that the value has stabilized at 0.47. The US-based tech center is accelerating drug discovery by implementing precision medicine. High confidence in the RADR platform confirms the company's status as a progressive innovator in lung cancer treatment.

Lantern Pharma (LTRN) - Dana dhuwit saben saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Lantern Pharma Inc.

- rega saham lan konsensus proyeksi valuasi:
- indikator kapitalisasi pasar:
- data dhuwit lan arus kas:
Ringkesan analisis perusahaan:Lantern Pharma - LTRN
Barang unggulan Lantern Pharma Inc

For Lantern Pharma Inc. (LTRN), which utilizes AI in cancer therapy, this indicator determines the liquid safety cushion per share of capital. The metric calculates the specific volume of cash, excluding temporary lags between quarterly reports. By analyzing the cash-per-share trend, an investor assesses the business's financial stability. The digitalization of research reduces operating expenses, optimizing resource expenditure. This confirms the company's ability to sustain innovation without emergency secondary offering financing.